Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV (Ac) P) for multiple myeloma
Takagi, T.; Oguro, M.; Sakai, C.
Japanese Journal of Clinical Hematology 27(12): 2249-2253
1986
ISSN/ISBN: 0485-1439
PMID: 3471977
Accession: 039604403
PDF emailed within 1 workday: $29.90
Related References
Glueck, S.; Schoppe, W.D.; Schneider, W. 1986: Vincristine cyclophosphamide melphalan prednisolone chemotherapy of multiple myeloma after ineffective melphalan prednisolone therapy Blut 53(3): 227Shimizu, K.; Kamiya, O.; Hamajima, N.; Mizuno, H.; Kobayashi, M.; Hirabayashi, N.; Takeyama, H.; Kato, R.; Kawashima, K.; Nitta, M. 1990: Multi-drug combination therapy with vincristine-melphalan-cyclophosphamide-prednisolone was more effective than cyclophosphamide-prednisolone in stage IIi myeloma. the Nagoya Myeloma Cooperative Study Group Japanese Journal of Cancer Research: Gann 81(12): 1320-1327
Peest, D.; Schmoll, H.J.; Schedel, I.; Deicher, H.; Boll, I.; Essers, U.; Gamm, H.; Glueck, S.; Goerg, K.; E.A. 1986: Melphalan and prednisolone vs. vincristine cyclophosphamide melphalan and prednisolone a prospective randomized trial in stage ii and iii multiple myeloma Journal of Cancer Research and Clinical Oncology 111(Suppl): S8
Kazuyuki Shimizu; Osamu Kamiya; Nobuyuki Hamajima; Harumitsu Mizuno; Masahide Kobayashi; Noriyuki Hirabayashi; Hideo Takeyama; Ryoichi Kato; Kohei Kawashima; Masakazu Nitta; Tomomitsu Hotta; Makoto Utsumi; Eiichi Nagura 1990: Multi-drug Combination Therapy with Vincristine-Melphalan-Cyclophosphamide-Prednisolone Was More Effective than Cyclophosphamide-Prednisolone in Stage III Myeloma Cancer Science 81(12): 1320-1327
Shimizu K.; Kamiya O.; Hamajima N.; Mizuno H.; Kobayashi M.; Hirabayashi N.; Takeyama H.; Kato R.; Kawashima K.; Et Al 1990: Multi drug combination therapy with vincristine melphalan cyclophosphamide prednisolone was more effective than cyclophosphamide prednisolone in stage iii myeloma Japanese Journal of Cancer Research 81(12): 1320-1326
Ishii, H. 1988: Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine Acta Medica Okayama 42(3): 175-182
Case, D.C.; Sonneborn, H.L.; Paul, S.D.; Hayes, D.M.; Dorsk, B.M.; Carroll, R.J.; Bove, L. 1985: Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol) Oncology 42(3): 137-140
Tirelli, U.; Crivellari, D.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol) Cancer Treatment Reports 66(11): 1971-1973
Majumdar, G.; Ganguly, K.; Kashyap, S.; Bardhan, G. 1998: Cyclophosphamide-idarubicin-dexamethasone An effective oral combination chemotherapy for melphalan-prednisolone resistant multiple myeloma British Journal of Haematology 102(1): 352
Kabir, A.L.; Rahman, M.J.; Begum, M.; Dipta, T.F.; Baqui, M.N.; Aziz, A.; Rahman, F.; Debnath, R.C.; Habib, M.A. 2012: Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma Mymensingh Medical Journal: Mmj 21(1): 114-119
Izumi, K. 1994: Studies on the effect of chemotherapy for multiple myeloma with analysis of bone lesion Part 1 Combination chemotherapy effect for multiple myeloma with aclarubicin, vincristine, cyclophosphamide and prednisolone including analysis on prognostic factors Okayama Igakkai Zasshi 106(3-4): 187-198
Snigurowicz, J.; Kraj, M.; Rostkowska, J.; Maj, S.; Mariańska, B.; Mendek, E.; Roszkowski, S.; Kilian, Z.; Kołakowski, L. 1981: Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone Archivum Immunologiae et Therapiae Experimentalis 29(2): 145-153
Keldsen, N.; Bjerrum, O.W.; Dahl, I.M.; Drivsholm, A.; Ellegaard, J.; Gadeberg, O.; Gimsing, P.; Grønvold, T.; Hansen, M.M.; Hippe, E. 1993: Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase IIi study. Nordic Myeloma Study Group (NMSG) European Journal of Haematology 51(2): 80-85
Poenisch, W.; Storch, H. 1987: Results of a cytostatic chemotherapy in outdoor patients with myeloma disease using a modified vincristine melphalan cyclophosphamide and prednisolone scheme Wissenschaftliche Zeitschrift der Karl-Marx-Universitaet Leipzig Mathematisch-Naturwissenschaftliche Reihe 36(5): 508-512
Le Loët, X.; Monconduit, M.; Menard, J.F.; Deshayes, P.; Grobois, B.; Tanguy, A.; Prevost, E.; Piguet, H. 1984: Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma Revue du Rhumatisme et des Maladies Osteo-Articulaires 51(5): 263-267
Chou, T.; Tobinai, K.; Uike, N.; Asakawa, T.; Saito, I.; Fukuda, H.; Mizoroki, F.; Ando, K.; Iida, S.; Ueda, R.; Tsukasaki, K.; Hotta, T.; Aikawa, K.; Matsuda, S.; Nakata, M.; Oshimi, K.; Ohmachi, K.; Ohnishi, K.; Kinoshita, T.; Okamura, S.; Tsukada, J. 2011: Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112 Japanese Journal of Clinical Oncology 41(4): 586-589
Ishii, H. 1988: M-protein kinetics in multiple myeloma treated with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine in combination Acta Medica Okayama 42(5): 279-286
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Robak, T.; Krykowski, E.; Płuzańska, A.; Olszańska-Skorek, T.; Urbańska-Ryś, H.; Polkowska-Kulesza, E.; Błasińska-Morawiec, M.; Mazurowa, A. 1983: Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP) Polski Tygodnik Lekarski 38(16): 481-484
Takenaka, T.; Itoh, K.; Suzuki, T.; Utsunomiya, A.; Matsuda, S.; Chou, T.; Sai, T.; Sano, M.; Konda, S.; Ohno, T.; Mikuni, C.; Deura, K.; Yamada, T.; Mizorogi, F.; Nagoshi, H.; Tomonaga, M.; Hotta, T.; Kawano, K.; Tsushita, K.; Hirano, M.; Shimoyama, M. 2004: Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301 International Journal of Hematology 79(2): 165-173